December 24, 2019
Sunovion Pharmaceuticals, a US subsidiary of Sumitomo Dainippon Pharma, said on December 20 that the US FDA has accepted its resubmission for its apomorphine sublingual film for the treatment of Parkinson’s disease, with a target action date set for May...read more